Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The pulmonary vein-left atrium (PV-LA) junction is the anatomical region where the four pulmonary veins drain oxygenated blood into the left atrium of the heart (Source: StatPearls, Anatomy, Thorax, Heart Left Atrium). This area is histologically unique due to the presence of myocardial sleeves, which are extensions of atrial muscle that wrap around the proximal portion of the pulmonary veins (Source: Journal of Anatomy, The pulmonary vein-left atrial junction). These sleeves are the most common site for ectopic electrical triggers that initiate and maintain paroxysmal atrial fibrillation (Source: New England Journal of Medicine, Haissaguerre et al., 1998). While the PV-LA junction is not a molecular target like a receptor or enzyme, it is the primary focus of catheter-based ablation procedures, such as pulmonary vein isolation (PVI), which aim to create a conduction block to prevent abnormal impulses from entering the atrium (Source: JACC, Pulmonary Vein Isolation for Atrial Fibrillation). Pharmacological treatments for arrhythmias originating in this region typically target ion channels within the myocytes rather than the junction itself (Source: Circulation, Antiarrhythmic Drugs for Atrial Fibrillation). Therapeutic interventions at this site carry risks such as pulmonary vein stenosis and the rare but life-threatening atrio-esophageal fistula (Source: Heart Rhythm Journal, Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation).
Not a molecular drug target; the junction is targeted via physical ablation (radiofrequency, cryotherapy, or pulsed-field ablation) to achieve electrical isolation of the pulmonary veins from the left atrium.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pulmonary vein-left atrium junction (PV-LA junction).